Dr Creer studied at the University of Cape Town Medical School, graduating in 1991. He undertook his specialist medical training in London including the Royal Free Hospital, the London Chest and St Bartholomew’s Hospital. He is a fellow of the Royal College of Physicians and has been a specialist respiratory and general medicine physician since 2004.

He has a broad range of respiratory expertise including the assessment of common respiratory symptoms like cough (including longstanding cough, coughing excessive sputum and coughing up blood), breathlessness, wheezing, positive TB skin or TB blood tests and the investigation of possible lung cancers including the assessment of pulmonary nodules and people wanting Lung Cancer Screening. 

He has accumulated specialist expertise at clinical assessment and at interpreting chest x-rays, Chest CT scans and breathing tests which allows him to provide a comprehensive assessment of patients with chest complaints. He also performs Bronchoscopy and Endobronchial Ultrasound (EBUS-TBNA) having performed over 2000 bronchoscopies.

Dr Creer has an interest in Chest Infections specifically Bronchiectasis, Non-Tuberculous Mycobacterial Infection and Tuberculosis as well as expertise managing common respiratory conditions like Asthma, COPD, Unexplained breathlessness, Chronic cough, Lung cancer, Pneumothorax and Pulmonary embolism.

Recent publications:

• COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease. Brill SE, Jarvis HC, Ozcan E, Burns TLP, Warraich RA, Amani LJ, Jaffer A, Paget S, Sivaramakrishnan A, Creer DD. BMC Med. 2020 Jun 25;18(1):194. doi: 10.1186/s12916-020-01665-z. PMID: 32586323 Free PMC article.
• Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT. Tavare AN, Braddy A, Brill S, Jarvis H, Sivaramakrishnan A, Barnett J, Creer DD, Hare SS. Thorax. 2020 Jul;75(7):537-538. doi: 10.1136/thoraxjnl-2020-214916. Epub 2020 Apr 21. PMID: 32317269 Free PMC article. No abstract available. 
• Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. Stagg HR, Bothamley GH, Davidson JA, Kunst H, Lalor MK, Lipman MC, Loutet MG, Lozewicz S, Mohiyuddin T, Abbara A, Alexander E, Booth H, Creer DD, Harris RJ, Kon OM, Loebinger MR, McHugh TD, Milburn HJ, Palchaudhuri P, Phillips PPJ, Schmok E, Taylor L, Abubakar I; London INH-R TB study group. Eur Respir J. 2019 Oct 10;54(4):1900982. doi: 10.1183/13993003.00982-2019. Print 2019 Oct. PMID: 31371444 Free PMC article. 
• Improved treatment completion for tuberculosis patients: The case for a dedicated social care team. Izzard A, Wilders S, Smith C, Wickers M, Hart T, Dos Santos J, Booth H, Creer D, Cropley I, Lozewicz S, White J, Lipman M. J Infect. 2021 Mar;82(3):e1-e3. doi: 10.1016/j.jinf.2020.12.019. Epub 2020 Dec 24. PMID: 33359406 
• Systemic air embolism as a complication of percutaneous lung biopsy. Tavare AN, Patel A, Saini A, Creer DD, Hare SS. Br J Hosp Med (Lond). 2018 Feb 2;79(2):106-107. doi: 10.12968/hmed.2018.79.2.106. PMID: 29431489 No abstract available. 
• Ipsilateral Dual-Site, Same-Sitting Percutaneous Lung Biopsy: A Feasibility Study. Barnett J, Tavare AN, Khan S, Saini A, Creer DD, Hare SS. Cardiovasc Intervent Radiol. 2017 May;40(5):755-760. doi: 10.1007/s00270-016-1558-0. Epub 2017 Jan 11. PMID: 28078376 

Clinical Interests

• Respiratory Infections
• Asthma
• COPD
• Bronchectosis
• TB

• British Theracie Society British Sleep Society